qiagen n.v. (QIA:Xetra)
Manfred E. Karobath M.D.
Supervisory Director and Chairman of Compensation Committee, Qiagen NV
|Age||Total Calculated Compensation||This person is connected to 19 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. Manfred E. Karobath, M.D. served as the President of research and development and Executive Vice President of Rhne-Poulenc Rorer (now sanofi-aventis), a pharmaceutical company, from 1992 to 1999. In 1980, Dr. Karobath joined Sandoz Pharma in Basel, first, in drug discovery and later became Senior Vice President and Head of R&D, Switzerland. Dr. Karobath serves as the Chairman and Director of IDEA AG and Director of Cardion AG. Dr. Karobath has been a Supervisory ...
Spoorstraat 50Phone: 31 77 320 8400
Venlo, Limburg 5911 KJ
Board Members Memberships*
Chairman of the Board and Member of Supervisory Board
Director and Member of Compensation Committee
University of Vienna Medical School
Annual Compensation*There is no Annual Compensation data available.
|John L. Bishop||Chairman, Chief Executive Officer and Member of Equity Incentive Committee|
|Peter D. Meldrum Ph.D.||Chief Executive Officer, President and Director|
Myriad Genetics Inc.
|Stephen P. MacMillan||Chief Executive Officer, President and Director|
|Robert F. Friel||Chairman, Chief Executive Officer, President and Member of Finance Committee|
|Alexandre Mérieux||Chief Executive Officer, Director and Member of Strategy Committee|
|€544.9K||Compensation as of Fiscal Year 2013.|